50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today CTSO ranks #12700 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Cytosorbents Corporation Stock Forecast NASDAQ:CTSO

$4.75 (-5.38%)

Volume: 126k

Closed: Nov 26, 2021

Hollow Logo Score: -5.125

Cytosorbents Corporation Stock Forecast

$4.75 (-5.38%)

Volume: 126k

Closed: Nov 26, 2021

Score Hollow Logo -5.125
Which way will CTSO go? Request
Key Stats
Beta 0.61
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] The Cytosorbents Corporation stock currently holds an RSI14 at 19 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Very red day for Cytosorbents Corporation stock price after -5.38% fall in Friday trading session
(Updated on Nov 26, 2021)


Sell candidate since 2021-11-11 Loss -23.39%

The Cytosorbents Corporation stock price fell by -5.38% on the last day (Friday, 26th Nov 2021) from $5.02 to $4.75. During the day the stock fluctuated 5.26% from a day low at $4.75 to a day high of $5.00. The price has fallen in 7 of the last 10 days and is down by -23.39% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -78 thousand shares and in total, 126 thousand shares were bought and sold for approximately $596.32 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -44.55% during the next 3 months and, with a 90% probability hold a price between $2.29 and $3.09 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are few to no technical positive signals at the moment. The Cytosorbents Corporation stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.27 and $5.97. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, November 08, 2021, and so far it has fallen -26.92%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.25 between high and low, or 5.26%. For the last week the stock has had a daily average volatility of 5.37%.

Cytosorbents Corporation is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Cytosorbents Corporation stock A Buy?

Cytosorbents Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.125

Predicted Opening Price for Cytosorbents Corporation of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$4.83 $4.75 (Undervalued)
Strong Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Oct 14, 2021 "B. Riley" gave "" rating for CTSO. The price target was changed from $6.13 to 11.5%.

Volatility and Risk
Daily Average Volatility: 5.37 %
Overall Risk: Very High High Medium Low Very Low
Volatility
5.37 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $5.24
Price: $4.75
No Support Found

CTSO Insider Trading Show all Trades

INSIDER POWER

8.049

Last 100 transactions
Buy: 2 256 142 | Sell: 280 289 (Shares)
Date Action Amount Person Type
Nov 23, 2021 Buy 4 000 Bloch Kathleen P. Common Stock
Aug 31, 2021 Sell 4 000 Kraus Al Stock Option (right to buy)
Aug 31, 2021 Sell 4 000 Kraus Al Common Stock
Aug 31, 2021 Buy 4 000 Kraus Al Common Stock
Apr 12, 2021 Buy 49 450 Bloch Kathleen P. Common Stock
Show all Insider Trades
INSIDER POWER

8.049

Last 100 transactions
Buy: 2 256 142 | Sell: 280 289 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 5.08 7.02 %
4.99 5.01 %
4.93 3.76 %
Current price: 4.75
Support 4.74 -0.26 %
4.68 -1.50 %
4.58 -3.51 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 5.86 23.37 %
5.85 23.16 %
5.24 10.32 %
Current price 4.75
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Cytosorbents Corporation

Cytosorbents CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. Its principal product is CytoSorb device, an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis; for the adjunctive therapy in other critical care ap... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT